Second-eye cataract surgery in elderly women: a cost-utility analysis conducted alongside a randomized controlled trial

TH Sach, AJ Foss, RM Gregson, A Zaman, F Osborn, T Masud, RH Harwood

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

AimThe aim of this study was to evaluate the cost-effectiveness of second-eye cataract surgery for older women with minimal visual dysfunction in the eye to be operated on from a Health and Personal Social Services perspective, compared to waiting list controls who had already undergone first-eye cataract surgery.MethodsA cost-utility analysis was undertaken alongside a randomized controlled trial of second-eye cataract surgery in secondary care ophthalmology clinics. A total of 239 women over 70 years old with one unoperated cataract were randomized to cataract surgery (expedited, approximately 4 weeks) or control (routine surgery, 12 months wait). Outcomes were measured in terms of quality-adjusted life years (QALYs), with health-related quality of life estimated using the EuroQol EQ-5D.ResultsThe operated group had costs which were, on average, pound646 more than the control group (95% confidence interval, pound16-1276, P>0.04) and had a mean QALY gain of 0.015 (95% confidence interval, -0.039 to 0.068, P=0.59) per patient over 1 year. Therefore, the incremental cost-utility ratio was pound44 263 over the 1-year trial period. In an analysis modelling costs and benefits over patients' expected lifetime, the incremental cost per QALY was pound17 299, under conservative assumptions.ConclusionsSecond-eye cataract surgery is not likely to be cost-effective in the short term for those with mild visual dysfunction pre-operation. In the long term, second-eye cataract surgery appears to be cost-effective unless carer costs are included.
Original languageEnglish
Pages (from-to)276-283
Number of pages8
JournalEye
Volume24
Issue number2
Early online date15 May 2009
DOIs
Publication statusPublished - 2010

Cite this